期刊文献+

PPARγ基因靶向shRNA真核表达载体的构建及表达 被引量:1

Construction and expression of eukaryotic expression plasmids of shRNA targeting the PPARγ gene
下载PDF
导出
摘要 目的研究短发夹RNA(shorthairpin RNA,shRNA)真核表达载体在人脐静脉内皮细胞(human umbilical veinendo-thelial cell,HUVECs)中对人过氧化物酶体增殖物激活受体γ(PPARγ)基因表达的抑制作用。方法设计3条靶向PPARγ的shRNA,经退火成互补双链,克隆到质粒pGPU6/GFP/Neo中构建重组载体,经酶切鉴定和测序确认后,将3个重组表达载体转染到HUVECs,利用Western blot检测并筛选出抑制效果最好的重组表达载体。结果通过酶切鉴定和测序分析,靶向PPARγ的3个pGPU6/GFP/Neo-shR-NA重组载体构建成功,Western blot结果显示pGPU6/GFP/NeoshRNAPPARγ3可有效抑制高糖诱导HUVECs中PPARγ基因的表达,抑制率为63.2%。结论 PPARγ基因靶向shRNA真核表达载体构建成功,且能有效抑制HUVECs中PPARγ基因的表达。 Aim To construct eukaryotic expressing plasmids of short hairpin RNA(shRNA) targeting the PPARγ gene and to evaluate their inhibitory effect on PPARγ expression in human umbilical veinendothelial cells(HUVECs).Methods Three pairs of complementary shRNA oligonucleotides targeting the PPARγ gene were designed,synthesized,annealed and inserted into the pGPU6/GFP/Neo plasmid.The recombinant plasmids were identified by restriction enzyme analysis and sequence analysis.The inhibitory effect of recombinant plasmids on PPARγ expression in HUVECs was detected by Western blot.Results After restriction enzyme analysis and sequence analysis,three eukaryotic expression plasmids of shRNA targeting the PPARγ gene were successfully constructed.Western blot analysis showed that pGPU6/GFP/NeoshRNAPPARγ3 reduced PPARγ expression by 63.2% in HUVECs induced with high glucose.Conclusion Three eukaryotic expression plasmids of shRNA targeting the PPARγ gene are successfully constructed.These recombinant plasmids can efficiently inhibit PPARγ expression in HUVECs.
出处 《中国药理学通报》 CAS CSCD 北大核心 2012年第7期1023-1026,共4页 Chinese Pharmacological Bulletin
基金 国家自然科学基金资助项目(No 81070633) 江西省研究生创新专项资金资助项目(No YC 09A012)
关键词 过氧化物酶体增殖物激活受体Γ 胰岛素抵抗 短发夹RNA RNA干扰 真核表达载体 糖尿病 磷脂酰肌醇3激酶 PPARs; insulin resistance; small hairpin RNA; RNA interfereence; recombinant plasmid; diabetes; PI3K
  • 相关文献

参考文献6

  • 1Braissant O, Foufelle F, Scotto C, et al. Differential expression of peroxisome proliferator-activated receptors (PPARs) : tissue distri- bution of PPAR-alpha, -beta, and -gamma in the adult rat [ J ]. Endocrinology, 1996,137 ( 1 ) :354 - 66.
  • 2环奕,申竹芳.选择性PPARγ调节剂治疗糖尿病的研究新进展[J].中国药理学通报,2008,24(2):149-152. 被引量:11
  • 3Deng T, Shan S, Li P P, et al. Peroxisome proliferator-activated re- ceptor gamma transcriptionally up-regulates hormone-sensitive li- pase via the involvement of specificity protein-1 [ J ]. Endocrinolo- gy,2006,147 (2) : 875 - 84.
  • 4Olefsky J M, Li P P, Nalbandian S. Adipocyte NCoR knockout de- creases PPAR phosphorylation and enhances PPAR activity and in- sulin sensitivity [ J ]. Cell, 2011,147 (4), 815 - 26.
  • 5Genini D, Carbone G M, Catapano C V. Multiple interactions be- tween peroxisome proliferators-activated receptors and the ubiquit- in-proteasome system and implications for cancer pathogenesis [ J ]. PPAR Res ,2008,2008 : 195065.
  • 6马悦颖,刘建勋.AS炎性信号通路与中医药干预[J].中国药理学通报,2011,27(6):745-747. 被引量:12

二级参考文献30

  • 1严瑾,沃兴德,范春雷,高丽萍,钱颖,宋家梁.山楂叶总黄酮对PPARγ-PPRE信号调控系统的影响[J].中国药学杂志,2005,40(8):625-628. 被引量:22
  • 2葛恒,张俊峰,王彬尧,王长谦.白藜芦醇对PPAR-γ激动作用的研究[J].中国药学杂志,2005,40(12):905-908. 被引量:15
  • 3陈娜,吴英良.PPARδ的结构及其生物学功能与疾病[J].中国药理学通报,2006,22(9):1035-1038. 被引量:11
  • 4方微,张慧信,王绿娅,秦彦文,武迎,王伟,刘斌.何首乌总苷抗氧化与实验性小鼠主动脉粥样硬化病变的形成[J].中国中药杂志,2007,32(13):1320-1323. 被引量:21
  • 5Mukherjee R, Hoener P A, Jow L, et al. A selective peroxisome proliferator-activated receptor-gamma(PPARgamma) modulator blocks adipocyte differentiation but stimulates glucose uptake in 3T3-L1 adipocytes[ J]. Mol Endocrinol,2000,14(9) :1425-33.
  • 6Nissen S E ,Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes[ J ]. N Engl J Med,2007,356 (24) :2457-71.
  • 7Miles P D, Barak Y, He W, et al. Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency [ J ]. J Clin Invest, 2000,105 ( 3 ) :287-92.
  • 8Laplante M, Sell H, MacNaul K L,et al. PPAR-gamma activation mediates adipose depot-specific effects on gene expression and lipoprotein lipase activity:mechanisms for modulation of postprandial lipemia and differential adipose accretion [ J ]. Diabetes, 2003,52 (2) :291-9.
  • 9Boden G, Cheung P, Mozzoli M,et al. Effect of thiazolidinediones on glucose and fatty acid metabolism in patients with type 2 diabetes [ J ]. Metabolism,2003,52:753-9.
  • 10Despres J P, Lemieux I. Abdominal obesity and metabolic syndrome [J]. Nature,2006,444(7121 ) :881-7.

共引文献21

同被引文献10

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部